Asthma Flashcards

1
Q

Where?

A

Conducting airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bronchoconstriction

From?

A
  • vagal innervation (para)
  • Ach, Methacholine
  • histamine
  • decrease in PACO2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bronchodilation

From?
Difference night vs. day?

A

B2 adrenergic receptors, circulating catecholamines

Less catecholamines at night, so worse s/s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Obstructive Ventilatory Defect

Which diseases?

A
  • Asthma,
  • chronic obstructive bronchitis,
  • bronchiectasis,
  • emphysema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Up turbulence = _______ pressure needed?

A

More

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MMEFR (FEF25-75)

Use?

A

Smaller airway dz

Maximum mid-expiratory flow rate
Forced expiratory flow over the middle half of FVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PEFR (FEFmax)

Name?
Use?

A

Peak expiratory flow rate

Highest expiratory flow achieved

Good for home monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Normal FEV/VC

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Obstructive FEV/VC

A

40%, total amount of both down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of airway obstruction in asthma

A

Secretions
Wall inflammation
Bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lower FEV1/FVC % =

A

Obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Type of expression in asthma cell

A

Th2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic _______ bronchitis

A

Eosinophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Low V/Q mismatch –>

A

Low V/Q units –> localized alveolar hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Induce bronchoconstriction

What?
Why?

A

Methylcholine

Resembles Ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to show hyperresponsiveness?

A

Earliness of Fall of FEV1 w/ methacholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

s/s of asthma

A
  • cough
  • wheezing
  • dyspnea
  • chest tightness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Asthma s/s with no respiratory inflammation?

A

Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  • childhood onset
  • FH = atopy
  • preceeded by allergic rhinitis, urticaria, eczema
  • triggered by environment
  • prick test
A

Allergic (atopic) asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

*up to 4 weeks
*AWHR up
*w/ RSV, Rhinovirus
*NEUTROPHIL RESPONSE 1st, then eosinophil
*

A

Respiratory virus asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Exercise-induced asthma

Mech?

A

From amount of heat energy needed to humidify + warm air

22
Q

Comorbid conditions that can trigger

A

Sinusitis
GERD
Obstructive Sleep Apnea
ABPA

23
Q

Asthma evaluation

A
  • ID triggers
  • ID comorbid conditions
  • Med treatment hx
  • severity
24
Q

Asthma Dx

A

Spirometry b/f and after spirometry w/ bronchodilator

If normal but suspect = methacholine challenge

25
Long term goals Tx
* Symptom control * Risk reduction NEED GOOD RELATIONSHIP w/ Patient
26
control =
* s/s * airway obstruction * effect on life SYMPTOM + FUTURE RISK
27
Severity categories
Mild Moderate Severe
28
Severity Impairment =
Patients recall of symptoms Activity levels Lung function
29
Control key s/s
* Daytime s/s * nocturnal wakening * frequency of SABA use * inability to perform activity
30
Asthma control
* 4 key s/s * monitoring pulmonary function * monitoring history of AE/asthma * monitor pharmacology (compliance/technique) * adjust therapy as needed
31
Rescue inhalor use in controlled asthma
2x per week | Inhalor lasts 50 weeks
32
When should see follow-up to reassess?
Every 3 months If stepped up : (sustained) 2-3 months (Short term) 1-2 weeks
33
Asthma Nasal Polyps ASA/NSAID allergy
Samter's Triad = atopic dermatitis
34
Path Airway hyperreactivity Cell type? 2 types?
Early IgE --> T cell * Extrinsic - allergic triggers * Intrinsic - non-allergic triggers (infection/URI, Rx, occupation, cold)
35
Path Bronchoconstriction physics? result?
airway narrowing, up resistance, down EXPIRATORY flow result : airway remodeling
36
Path Inflammation Why?
cellular infiltration (T lymph, neutro, eosino = leukotrienes) UP histamine (igE)
37
S/s classic triad
dyspnea wheezing cough =/- chest tightness
38
* inability to complete sentence * altered mental * pulsus paradoxicus (inspiratory DOWN SBP>10) * cyanosis * tripod * silent chest * tac = cardio pulm
Severe asthma | Status asthmaticus
39
SABAs
Albuterol Levalbuterol Terbutaline Epi
40
Antichol short term
ipatroprium
41
Corticosteroids long term
Beclomethasone, Flunisolide, Triamcinolone 1st line - long term
42
LABAs
Salmeterol Symbicort (Budesonide/Formoterol) Advair (fluticasone/Salmeterol)
43
Mast cell modifiers
Cromolyn | Nedocromil
44
Leukotriene inhibitors
Monteleukast Zafirlukast Zileuton Theophylline Asthmatics w/ aspirin induced/allergic rhinitis
45
* less than 2 attacks per day/week | * Normal FEV1
intermittent Inhaled SABA as needed
46
* 2+ days a week, but NOT daily or +1 in a day (same SABA) * FEV1 > 80% * FEV1/FVC normal * 3-4 night awakenings/month
Mild Inhaled SABA Low dose ICS
47
* Daily s/s ~ SABA daily * >1 night awakening / week (not daily) * FEV1 = 60-80% * FEV1/FVC = DOWN 5%
Moderate ``` *Low ICS + LABA OR *UP ICS dose OR *+ LTRA ```
48
* s/s throughout day * SABA several times a day * night awakening usually every night * FEV1= <60% * FEV1/FVC= DOWN 5%
Severe High dose ICS + LABA +/- Omalizumab (anti - IgE)
49
GINA Stepwise treatment
*Step 2= low dose ICS OR LTRA/Low theophylline *Step 3=Low dose ICS/LABA Step 4= Med/high ICS/LABA Setp 5= Add-on Tx (tiotropium, anti-IgE, Anti-IL5
50
Asthma Interview
* S/S + pattern * Triggers * Dz developtment/treatment * FH * Social (home//tobacco/occupation) * Exacerbation profile * impact on patient/family * Patient's perception of dz
51
Essential to Dx?
Spirometry | Show AWO
52
Anti IgE Rx
Omalizumab *severe, uncontrolled